Item 5.07 Submission of Matters to a Vote of Security Holders
Forma Therapeutics Holdings, Inc. (the "Company") held its Annual Meeting of
Stockholders on June 17, 2021 (the "Annual Meeting"). At the Annual Meeting, the
Company's stockholders considered and voted on the two proposals set forth
below, each of which is described in greater detail in the Company's Proxy
Statement, filed with the Securities and Exchange Commission on April 21, 2021.
The final voting results are set forth below.
Proposal 1 - Election of Class I Director Nominees
The stockholders of the Company elected Selwyn M. Vickers, M.D. and Wayne A.I.
Frederick, M.D. as Class I directors of the Company, for a three-year term
ending at the annual meeting of stockholders to be held in 2024 and until their
successor have been duly elected and qualified or until their earlier
resignation or removal. The results of the stockholders' vote with respect to
the election of the Class I directors were as follows:
Votes Votes Broker
Name For Withheld Non-Votes
Selwyn M. Vickers, M.D. 32,867,626 242,988 1,796,704
Wayne A.I. Frederick, M.D. 32,867,630 242,984 1,796,704
Proposal 2 - Ratification of Appointment of the Company's Independent Registered
Public Accounting Firm
The stockholders of the Company ratified the selection of Ernst & Young LLP as
the Company's independent registered public accounting firm for the fiscal year
ending December 31, 2021. The results of the stockholders' vote with respect to
such ratification were as follows:
Votes Votes Votes Broker
For Against Abstain Non-Votes
34,904,928 2,035 355 0
No other matters were submitted to or voted on by the Company's stockholders at
the Annual Meeting.
1
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses